|
시장보고서
상품코드
2051089
계산생물학 시장 : 유형별, 툴별, 지역별Computational Biology Market, By Type, By Tools, By Geography |
||||||
계산생물학 시장은 2026년에 107억 6,000만 달러로 추정되며, 2033년까지 338억 6,000만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 17.8%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 107억 6,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 17.80% | 2033년 시장 규모 예측 : | 338억 6,000만 달러 |
계산생물학은 질병에 대한 계산 모델을 개발하고, 환자 데이터를 사용하여 이러한 모델을 개인화하여 의료 진단 및 치료 개선에 적용함으로써 의료의 진보를 목표로 합니다. 이러한 환자 모델은 암, 심혈관질환, 신경질환 등의 응용에서 새로운 위험 바이오마커 발굴, 질병 진행 예측, 최적의 치료법 설계, 신규 약물 타겟 발굴 등에 활용됩니다. 환자별 정량적 모델 개발 및 적용은 질병의 이해, 진단, 치료에 활용될 수 있습니다. 계산의학은 분자 의학, 생리학, 해부학 분야에서 활용될 수 있습니다. 생의학 신호 처리, 계산 모델링, 머신러닝, 헬스 인포매틱스를 통합하여 전자 건강 기록, 생리적 시계열 데이터, 유전체학을 활용한 맞춤형 의료에 대한 새로운 접근법을 개발할 수 있습니다.
시장 역학
주요 시장 기업의 신제품 출시, 합병 및 인수합병이 증가함에 따라 세계 계산생물학 시장의 성장을 견인할 것으로 예측됩니다. 예를 들어, 2022년 7월 25일, 미국에 본사를 둔 유전체 분석 기업 리플레이(Replay)는 5,500만 달러의 시드 펀딩을 진행했습니다. 이번 라운드는 KKR과 OMX Ventures가 주도했으며, ARTIS Ventures, Lansdowne Partners, SALT, DeciBio Ventures, Axial이 추가로 참여했습니다. Replay의 유전체 의료 툴킷은 고부하 용량 HSV 전달 플랫폼, 저면역원성 세포치료제 플랫폼, 독자적인 유전체 라이팅 플랫폼 등 빅 DNA를 작성하고 전달하기 위한 혁신적인 플랫폼 기술 포트폴리오를 포괄하고 있습니다. 미국에 본사를 둔 유전체 라이팅 기업 리플레이(Replay)는 페이로드 용량 증가, 비용 절감, 생산 속도, 수량 및 일관성 향상, 유전체 엔지니어링의 잠재력 확대 등 현재 임상 진전을 제한하고 있는 문제를 해결하기 위해 노력하고 있습니다.
본 조사의 주요 특징
- 이 보고서는 다양한 부문의 잠재적 수익 창출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 보고서는 다음과 같은 매개변수(기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 기반으로 세계 계산생물학 시장의 주요 기업 프로파일을 작성했습니다.
- 이 조사에 포함된 주요 기업으로는 Accelrys, Certara, L.P., Chemical Computing Group Inc. Insilico Biotechnology AG, Leadscope, Inc., Nimbus Discovery LLC, Rhenovia Pharma SAS, Schrodinger, 그리고 Simulation Plus, Inc.
- 이 보고서는 각 기업의 마케팅 담당자와 경영진이 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략과 관련하여 정보에 입각한 의사결정을 내릴 수 있도록 돕습니다.
- 이 세계 계산생물학 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 계산생물학 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 계산생물학 시장 : 유형별, 2021년-2033년
제5장 세계의 계산생물학 시장 : 툴별, 2021년-2033년
제6장 세계의 계산생물학 시장 : 지역별, 2021년-2033년
제7장 경쟁 구도
제8장 섹션
LSH 26.06.17Computational Biology Market is estimated to be valued at USD 10.76 Bn in 2026 and is expected to reach USD 33.86 Bn by 2033, growing at a compound annual growth rate (CAGR) of 17.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 10.76 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 17.80% | 2033 Value Projection: | USD 33.86 Bn |
Computational biology aims to advance healthcare by developing computational models of diseases, personalizing these models using data from patients, and applying these models to improve the diagnosis and treatment of diseases. These patient models are used to discover novel risk biomarkers, predict disease progression, design optimal treatments, and identify new drug targets for applications such as cancer, cardiovascular disease, and neurological disorders. The development and application of patient-specific, quantitative models can be used to understand, diagnose, and treat disease. Computational medicines can be used for molecular, physiological, and anatomical medicines. The integration of biomedical signal processing, computational modeling, machine learning, and health informatics can be done to develop new approaches in personalized medicine via electronic health records, physiological time series data, and genomics.
Market Dynamics
The increasing launch of new products, mergers, and acquisitions by key market players is expected to drive the global computational biology market growth. For instance, on July 25, 2022, Replay, a U.S.-based genome writing company, received USD 55 Mn in seed financing. The round was led by KKR and OMX Ventures, with additional participation from ARTIS Ventures and Lansdowne Partners, SALT, DeciBio Ventures, and Axial. Replay's genomic medicine toolkit encompasses a portfolio of disruptive platform technologies to write and deliver big DNA, including a high payload capacity HSV delivery platform, a hypoimmunogenic cell therapy platform, and a proprietary genome writing platform. The Replay, a U.S.-based genome writing company solves challenges in currently limiting clinical progress including increased payload capacity, off the shelf cell therapies that can reduce the cost of goods, improve production speed, volume and consistency, and expand the potential for genome engineering.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global computational biology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- The key companies covered as a part of this study include Accelrys, Certara, L.P., Chemical Computing Group Inc., Compugen, Ltd., Entelos, Inc. (Rosa & Co. LLC), Genedata AG, Insilico Biotechnology AG, Leadscope, Inc., Nimbus Discovery LLC, Rhenovia Pharma SAS, Schrodinger, and Simulation Plus, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global computational biology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global computational biology market.
Market Segmentation
- Global Computational Biology Market, By Type (Revenue, USD Bn, 2021 - 2033)
- Cellular and Biological Simulation
- Computational Genomics
- Computational Proteomics
- Pharmacogenomics
- Others (Transcriptomics/Metabolomic)
- Disease Modeling and Simulation Applications
- Drug Discovery
- Drug Development
- Global Computational Biology Market, By Tools (Revenue, USD Bn, 2021 - 2033)
- Content/Database
- Analysis Software and Services
- IT Infrastructure (Hardware)
- Global Computational Biology Market, By Region (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- U.K.
- Germany
- France
- Spain
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- North Africa
- Central Africa
- South Africa
- Company Profiles
- Accelrys
- Certara, L.P.
- Chemical Computing Group Inc.
- Compugen, ltd.
- Entelos, Inc. (Rosa & Co. LLC)
- Genedata AG
- Insilico Biotechnology AG
- Leadscope, Inc.
- Nimbus Discovery LLC
- Rhenovia Pharma SAS
- Schrodinger
- Simulation Plus, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Tools
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Computational Biology Market, By Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Cellular and Biological Simulation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Computational Genomics
- Computational Proteomics
- Pharmacogenomics
- Others (Transcriptomics/Metabolomic)
- Disease Modeling and Simulation Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Drug Discovery
- Drug Development
5. Global Computational Biology Market, By Tools, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Content/Database
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Analysis Software and Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- IT Infrastructure (Hardware)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Computational Biology Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Tools, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Tools, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Tools, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Tools, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Tools, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Tools, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2021 - 2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
7. Competitive Landscape
- Accelrys
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Certara, L.P.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Chemical Computing Group Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Compugen, ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Entelos, Inc. (Rosa and Co. LLC)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Genedata AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Insilico Biotechnology AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Leadscope, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Nimbus Discovery LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Rhenovia Pharma SAS
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Schrodinger
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Simulation Plus, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
8. Section
- Research Methodology
- About Us
